Ms Eastham has been elected to serve as a class I director of Genoptix until the 2011 annual meeting of stockholders and will also serve on the audit committee of the board of directors.
Dr McCarthy has been elected to serve as a class II director of Genoptix until the 2009 annual meeting of stockholders and will also serve on the compliance committee of the board of directors.
Prior to Genoptix, Ms Eastham was the senior vice president of finance and the CFO for Diversa. Dr McCarthy is a venture partner with Ampersand Ventures and president of Scientific Technologies and Solutions. These additions bring the total number of members serving on the Genoptix board to nine.
Tina Bennett, president and CEO of Genoptix, said: “We look forward to the contributions of Ms Eastham and Dr McCarthy as members of the Genoptix board of directors. Each bring their individual expertise in their fields and personal style of leadership, adding diversity of opinion and further strengthening the leadership of the company as we move forward.”